Literature DB >> 16937746

Clinical history as a predictor of penicillin skin test outcome.

Benjamin B L Wong1, Paul K Keith, Susan Waserman.   

Abstract

BACKGROUND: Up to 10% of the population reports an "allergy" to penicillin, whereas approximately 1.1% has positive penicillin skin test results. Where penicillin skin tests are unavailable, some have advocated using history to decide whether to use a penicillin-related antibiotic.
OBJECTIVE: To determine if clinical history predicts penicillin skin test results.
METHOD: Retrospective medical record review of 94 consecutive patients who had previously taken penicillin referred for penicillin allergy. Case histories were taken, penicillin skin tests performed, and an oral challenge recommended if skin test results were negative.
RESULTS: Of 91 cases studied, the average patient age was 27 years (range, 6 months to 82 years; 36% female). Fifty-two (57%) experienced hives as their main adverse reaction. Sixteen (18%) had at least 1 positive test result. Of this group, 9 had hives as their main symptom, whereas 1 had respiratory problems and 1 had angioedema. Most patients with positive skin test results had experienced their reaction at least 3 years ago. Regression analysis showed that age, sex, and clinical history, including type of reaction, time of reaction after penicillin ingestion, or time since the last reaction, were not associated with skin test positivity. Seventy-two (96%) of the 75 patients who had negative skin test results underwent oral challenge. Seventy had negative challenge results. The negative predictive value of a negative penicillin skin test result was 97%.
CONCLUSION: Clinical history was not predictive of subsequent penicillin skin test results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937746     DOI: 10.1016/S1081-1206(10)60008-7

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  8 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Group B Streptococcus prophylaxis in patients who report a penicillin allergy: a follow-up study.

Authors:  Agatha S Critchfield; Stacey P Lievense; Christina A Raker; Kristen A Matteson
Journal:  Am J Obstet Gynecol       Date:  2010-12-17       Impact factor: 8.661

Review 3.  Immediate-type hypersensitivity drug reactions.

Authors:  Shelley F Stone; Elizabeth J Phillips; Michael D Wiese; Robert J Heddle; Simon G A Brown
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

4.  Accuracy of penicillin allergy diagnostic tests: A systematic review and meta-analysis.

Authors:  Bernardo Sousa-Pinto; Isabel Tarrio; Kimberly G Blumenthal; Luís Araújo; Luís Filipe Azevedo; Luís Delgado; João Almeida Fonseca
Journal:  J Allergy Clin Immunol       Date:  2020-05-21       Impact factor: 10.793

5.  Penicillin skin testing in the management of penicillin allergy in an outpatient pediatric population.

Authors:  Christine M Anterasian; Bob Geng
Journal:  Allergy Asthma Proc       Date:  2018-07-01       Impact factor: 2.873

6.  Clinical history in suspected cases of immediate allergy to beta-lactam.

Authors:  Yossi Rosman; Mohamad Elmalak; Keren Meir-Shafrir; Idit Lachover-Roth; Anat Cohen-Engler; Ronit Confino-Cohen
Journal:  World Allergy Organ J       Date:  2021-01-22       Impact factor: 4.084

7.  Frequency of severe reactions following penicillin drug provocation tests: A Bayesian meta-analysis.

Authors:  António Cardoso-Fernandes; Kimberly G Blumenthal; Anca Mirela Chiriac; Isabel Tarrio; David Afonso-João; Luís Delgado; João Almeida Fonseca; Luís Filipe Azevedo; Bernardo Sousa-Pinto
Journal:  Clin Transl Allergy       Date:  2021-06       Impact factor: 5.871

8.  Antibiotic skin testing accompanied by provocative challenges in children is a useful clinical tool.

Authors:  Fotini D Kavadas; Anna Kasprzak; Adelle R Atkinson
Journal:  Allergy Asthma Clin Immunol       Date:  2013-06-14       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.